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Abstract
Background: Colorectal surgery (CRS) patients are an at-risk population who are particularly vulnerable to
postoperative infectious complications. Infectious complications range from minor infections including simple
cystitis and superficial wound infections to life-threatening situations such as lobar pneumonia or anastomotic leak
with fecal peritonitis. Within an enhanced recovery pathway (ERP), there are multiple approaches that can be used
to reduce the risk of postoperative infections.
Methods: With input from a multidisciplinary, international group of experts and through a focused (non-
systematic) review of the literature, and use of a modified Delphi method, we achieved consensus surrounding the
topic of prevention of postoperative infection in the perioperative period for CRS patients.
Discussion: As a part of the first Perioperative Quality Initiative (POQI-1) workgroup meeting, we sought to develop a
consensus statement describing a comprehensive, yet practical, approach for reducing postoperative infections,
specifically for CRS within an ERP. Surgical site infection (SSI) is the most common postoperative infection. To reduce
SSI, we recommend routine use of a combined isosmotic mechanical bowel preparation with oral antibiotics before
elective CRS and that infection prevention strategies (also called bundles) be routinely implemented as part of
colorectal ERPs. We recommend against routine use of abdominal drains. We also give consensus guidelines for
reducing pneumonia, urinary tract infection, and central line-associated bloodstream infection (CLABSI).
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Summary of consensus statements
Preventing SSI
1. Defining incisional vs. abdominopelvic infectious
complications: We recommend reporting and
analyzing incisional (superficial and deep) surgical
site infections (SSIs) separately from organ space
(abscess/leak) SSIs as they are inherently different in
both risk factors and consequences.
2. Drain use and abdominopelvic infectious
complications: We recommend against routine use
of abdominal drains. Pelvic drain use should be left
to the surgeon’s discretion.
3. Infection prevention bundles: We recommend that
infection prevention strategies (also called bundles)
be routinely implemented as part of colorectal
enhanced recovery pathways (ERPs).
4. Combined mechanical bowel prep (MBP) and oral
antibiotics (OAs): We recommend routine use of a
combined isosmotic MBP with OA before elective
colorectal surgery.
5. Mechanical bowel prep alone: We do not
recommend use of MBP without concurrent OA
before elective colorectal surgery.
6. Isosmotic vs. hyperosmotic mechanical bowel prep:
We recommend against the use of hyperosmotic
MBP solutions before elective colorectal surgery.
Preventing pneumonia and aspiration
7. Risk assessment: We suggest preoperative risk
assessment for aspiration and pneumonia be
routinely implemented in colorectal ERPs.
8. Optimizing lung function: We recommend routine
use of intraoperative lung-protective strategies
during elective colorectal surgery.
9. Nasogastric tube use: We recommend against
routine use of postoperative nasogastric tube (NGT)
drainage after elective colorectal surgery.
10. Recognizing ileus: We recommend early recognition
and treatment of postoperative ileus. This includes
NGT insertion when appropriate.
Preventing urinary tract infection
11.Optimal urinary catheter use: We recommend early
urinary catheter removal (within 24 h) after elective
colon surgery. Timing of catheter removal after
pelvic surgery should be left to the surgeon’s
discretion.
12.Managing early postoperative urinary retention: We
recommend that for patients who fail trial of void,
clean intermittent catheterization for 24 h be
considered after elective colorectal surgery.
Preventing CLABSI
13.Avoid routine central line use: We recommend
against routine central line use during elective
colorectal surgery.
14. Earliest possible removal of central lines: We
recommend that if a central line use is used, it
should be removed as soon as possible.
Background
Colorectal surgery (CRS) patients are an at-risk popula-
tion who are particularly vulnerable to postoperative in-
fectious complications for a variety of reasons. Primarily,
CRS carries a much higher risk of infection than any
other clean contaminated case owing to the high bacter-
ial inoculum of the colon and rectum. The colorectal
patient population is also characterized by a unique risk
factor profile related to underlying diagnoses such as
cancer (colorectal adenocarcinoma, anal squamous cell
cancer), the presence of active inflammation (diverticular
disease and inflammatory bowel disease), and conditions
that impair wound healing, such as prior radiochemother-
apy, steroids, and malnutrition. Additional complicating
factors of CRS include case complexity, perineal wounds,
combined multispecialty cases, and prolonged operative
times.
In recent years, the National Quality Improvement Pro-
ject (NSQIP) (https://www.facs.org/quality-programs/acs-
nsqip/program-specifics/participant-use) has allowed for a
better understanding of the frequency and risk factors
for individual postoperative complications (see http://
riskcalculator.facs.org/RiskCalculator/, and Fig. 1, an ex-
ample of the new calculator output which includes risk of
specific infections including urinary tract infection, pneu-
monia, surgical site infection [SSI], and even anastomotic
leak risk). More importantly, NSQIP provides a quality
improvement framework whereby individual hospitals and
multihospital collaboratives can leverage local, regional, or
disease-specific data to improve patient outcomes. A
review of recent NSQIP national data reveals an overall
complication rate for CRS of 21%, with three fourths
of those (15% overall) being infectious complications
(Table 1). These hospital-acquired conditions (HACs)
range from minor infections including simple cystitis
and superficial wound infections to life-threatening
situations such as lobar pneumonia or anastomotic
leak with fecal peritonitis.
In the last decade, enhanced recovery pathways (ERPs)
have emerged as the optimal approach to perioperative
care of colorectal patients. These evidence-based path-
ways definitively improved postoperative outcomes and
are associated with reduced length of stay (LOS) and
overall complications (Vlug et al. 2011; Walter et al.
2009). The Perioperative Quality Initiative (POQI) is a
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collaborative effort that brings together the perspectives
of experts representing the perioperative team including
anesthesia, surgery, nursing, and other perioperative care
providers. In this paper, we will address prevention of in-
fectious complications within an ERP for CRS.
Methods
On March 4–5, 2016, POQI-1 was held in Durham, NC.
Workgroups were composed of healthcare providers
(anesthesiologists, surgeons, and nurses) addressing four
topics (fluids, outcomes, analgesia, infections). POQI-1
was a consensus-building conference designed around a
modified Delphi process in which the group alternately
convened for plenary discussion sessions and then re-
tired for small group discussion. The recommendations
were developed over 2 days, and consensus was reached
around the main issues within each topic. The group
chairs and co-chairs were responsible for leading the dis-
cussions and delivered a manuscript summarizing the
group topic discussions and recommendations and sug-
gestions for future research.
Preventing surgical site infection
Defining incisional vs. abdominopelvic infectious
complications
We recommend reporting and analyzing incisional
(superficial and deep SSIs) separately from organ space
SSIs (abscess/leak), as they are inherently different in
both risk factors and consequences.
In CRS, it is important to differentiate between
incisional infections, also called wound infections, which
may or may not be associated with a deeper organ space
infection that represents an abdominopelvic abscess, anas-
tomotic leak, or enteric fistula. The NSQIP definitions of
surgical site infections (SSIs) are shown in Table 1. CRS
patients may have multiple incision sites of varying
lengths including minimally invasive port sites (<1.2 cm),
specimen extraction sites (2–4 cm), new and former os-
tomy sites (~3 cm), perineal wounds (<6 cm), hand-
assisted laparoscopic surgery (HALS) sites (7.5 cm), and
traditional laparotomy incisions (8 to 25+ cm). Given
their proximity to bowel contents, ostomy wounds
and perineal wounds are particularly prone to SSIs.
Fig. 1 American College of Surgeons Risk Calculator example output
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Superficial SSIs are common at a historic rate of 10 to
25% and are generally recognized clinically as wound
erythema, hyperemia, pain, or purulence. Superficial SSIs
are generally Clavien-Dindo (Dindo et al. 2004) grade 1
managed by opening the wound and allowing it to heal
by secondary intention, often with packing or vacuum
dressings. Adjuvant antibiotics are reserved for patients
with associated cellulitis >2 cm beyond the wound edge,
diabetics, or immunosuppressed patients.
Deep incisional SSIs involve the deep tissues, typically
the fascia, in the case of CRS. The development of a
deep incisional SSI is particularly morbid. These patients
often require operative debridement (Clavien-Dindo
grade 3), systemic antibiotics, and are associated with
fascial dehiscence and the subsequent development of
an incisional hernia. A comprehensive review of all pre-
ventative measures for incisional SSIs is beyond the
scope of this review. However, the Infectious Disease
Table 1 Definitions of perioperative infections
Type Rate infections,
n = 432,756
colorectal
proceduresa (%)
Median (interquartile
range) days from
operation to infectious
complication
NSQIP definitionsb Criteria
Any infectious
complication
15.1 – Composite variable of the below. N/A
Superficial SSI 5.3 9 (6–14) Infection involving only skin or
subcutaneous tissue of the incision.
Requires symptoms (pain, erythema,
swelling, heat) and presence of pus
or a positive culture or intentional
opening of the wound.
Deep incisional SSI 1.3 10 (6–16) Infection involving deep soft tissues.
Deep soft tissues are typically any
tissue beneath the skin and immediate
subcutaneous fat, for example, fascial
and muscle layers.
Pus must not be from organ space
or deep incision spontaneously
dehisces or is deliberately opened by
a surgeon when the patient has at
least one of the following signs or
symptoms: fever (>38 °C), localized pain,
or tenderness, unless the site
is culture-negative direct examination,
during reoperation, or by histo-pathologic
or radiologic examination radiographic
evidence of abscess.
Organ/space SSI 6.4 10 (7–16) Infection involving any part of the
anatomy (e.g., organs or spaces),
other than the incision, which
was opened or manipulated
during an operation.
Pus from a drain that is placed through
a stab wound into the organ/space.
Organisms isolated from an aseptically
obtained culture of fluid or tissue in the
organ/space. An abscess or other evidence
of infection involving the organ/space that
is found on direct examination,
during reoperation, or by histo-pathologic
or radiologic examination.
Pneumonia 2.5 5 (3–10) An infection of one or both lungs
caused by bacteria, viruses, fungi,
or aspiration. Pneumonia can be
community acquired or acquired
in a healthcare setting.
Requires CXR or CT chest evidence of
infiltrate, consolidation, opacity, or
cavitation as well as
2 signs, symptoms, or lab values.
UTI 2.6 9 (5–16) Infection in the urinary tract
(kidneys, ureters, bladder, and
urethra).
Requires 1 of the following 6 criteria: fever
(>38 °C or 100.4 °F), urgency, frequency,
dysuria, suprapubic tenderness,
costovertebral angle pain or tenderness
and a positive urine culture OR 2 of the
above criteria and 2 urine
cultures or empiric treatment for
presumptive UTI.
Sepsis 3.7 7 (3–13)
Septic shock 2.2 4 (1–9)
CLABSI – – Not presently included in NSQIP.
Definitions are available from the 2015 NSQIP Participant User File User
Guide: https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_user_guide_2015.ashx
aPreviously unpublished, courtesy of Dr. Holubar, NSQIP 2005–2014, CPT ranges 44xxx–46999
bLimited to first 30 days. All definitions may be superseded by surgeon documentation of the infection in the medical record
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Society of America Guidelines from 2014 provides an
excellent overview (Anderson et al. 2014). Important
preventative measures (Table 2) include but are not lim-
ited to preoperative smoking cessation, preoperative
chlorhexidine showering, clipping for hair removal, pre-
vention of hypothermia, appropriate selection, timing
and dosing of prophylactic antibiotics, optimization of
glucose control, use of an alcohol-containing skin prep,
use of a wound protector, meticulous surgical technique
with minimization of GI spillage, adherence to hand hy-
giene, and reducing unnecessary traffic in the operating
room (Yokoe et al. 2014). Infection prevention bundles
are discussed further below.
Organ space infections, as they pertain to CRS, include
abdominopelvic abscesses, anastomotic leak, and enteric
fistulae. Relative to incisional infections are less common
(<5%) and more morbid (classified as Clavien grades 3 to
5 as fecal peritonitis has a historic mortality rate in the
range of 30–50%). Although current mortality rates are
much improved, organ space infections are still a very
severe complication. Prevention of anastomotic leak
centers on constructing a tension-free, airtight, well-
perfused anastomosis in a non-contaminated field in a
stable patient; low pelvic anastomoses below 10 cm are
at increased risk of leak, thus often necessitating fecal
diversion via temporary loop ileostomy or colostomy.
Historically, the development of an anastomotic leak
was felt to be purely technical, related to ischemia,
tension, or impaired wound healing. However, clearly,
prevention of leaks—especially from an ERP perspective,
must take into account potentially reversible patient-
related factors such as protein-calorie malnutrition,
anemia, and cigarette smoking (Midura et al. 2015).
Drain use and abdominopelvic infectious complications
We do not recommend routine use of abdominal drains.
Pelvic drain use should be left to the surgeon’s discretion.
A 2004 Cochrane review found that routine drain use
for colorectal anastomoses is of no added benefit (De
Jesus EC 2009). More recently, this was confirmed by a
subsequent meta-analysis (Zhang et al. 2016). However,
it is important to note that these studies did not assign
any harm to the drain use either. One concern for the
presence of an indwelling drain from an ERP perspective
is that it will interfere with the patient’s ability to ambu-
late independently in the postoperative period; another
is potential for infection. As such, the avoidance of
drains is one of the primary tenets of ERPs, and we do
not recommend using abdominal drains routinely.
However, many colorectal surgeons feel that after proc-
tectomy—which results in a large dead space in the most
dependent portion of the abdominopelvic cavity—pelvic
drains may prevent or help recognize problems such as
pelvic hematomas and lymphatic or urinary tract disrup-
tion. As such, although pelvic drains should not be used
routinely, this decision should be left to the discretion of
the surgeon.
Infection prevention bundles
We recommend that surgical site infection prevention bun-
dles be routinely implemented as part of a colorectal ERP.
Recently, in an effort to maximally reduce postopera-
tive SSI occurrence, SSI prevention bundles have been
demonstrated to be effective in reducing SSI rates.
Specific bundles have been demonstrated in colorectal,
pancreatic resection, and liver resection (Cima et al.
2013; Lavu et al. 2012; Hill et al. 2015). A bundle is a
package of various perioperative practices all with the
common goal of reducing postoperative infectious
complications. Bundles are complementary to, and not
mutually exclusive to, ERP. Example practices include
preoperative optimization of anemia and diabetes;
preoperative chlorhexidine washes; proper antibiotic
Table 2 SSI prevention bundle elements
Phase of care Element
Preoperative at
home
Smoking cessation
Preoperative at
home
Diabetes optimization (check and treat HbA1c)
Preoperative at
home
Anemia optimization (folate, iron, vitamin C, Venofer)
Preoperative at
home
Chlorhexidine showers
Preoperative at
hospital
Clipping (not shaving) surgical site
Preoperative at
hospital
Chlorhexidine towelettes
Intraoperative Active warming to prevent hypothermia
Intraoperative Appropriate (selection, dose, timing) IV antibiotic
within 60 min of incision, discontinued within 24 h
Intraoperative Routine use of a wound protector
Intraoperative Routine use alcohol-containing skin prep
Intraoperative Routine intra-op high-concentration supplemental
oxygen
Intraoperative Reduce unnecessary traffic in the operating room
Intraoperative Routine use of separate fascial closure tray
or separate anastomotic tray
Global Adherence to hand hygiene
Global Active surveillance program with education,
compliance, and feedback
Global Optimize preoperative glucose control,
Maintain blood glucose <180 through POD 2
SHEA/IDSA practice recommendations 2014 (Causey et al. 2011). Note most
institutions surgical sub-specialties develop their own bundles to address local
issues by selecting a sub-set of the menu of elements listed
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selection; dosing, and re-dosing; active rewarming; and
prompt removal of artificial tubes and lines (Table 2).
The Mayo Clinic Rochester colorectal group (Cima et
al. 2013) used a multidisciplinary team to design and im-
plement their bundle. Quality improvement methods in-
cluding statistical process control charts, as well as
descriptive statistics, were used to assess the effective-
ness of the implementation of the bundle to reduce SSIs.
Bundle implementation was associated with an almost
50% reduction in SSIs (as measured by NSQIP) from
9.8% pre-implementation to just 4% after implementa-
tion. The Dartmouth colorectal group implemented a
similar bundle and, in a NSQIP series of 119 patients,
were able to achieve 1st quartile (exemplary status) with
an observed SSI rate of 3.4% vs. a predicted observed
rate of 6.1% and expected rate of 9.7% (odds ratio, 0.59,
95% confidence interval 0.34–1.03) (Holubar 2016).
Similarly, a study from the Duke colorectal group re-
ported on the sequential effect of first ERP and then their
bundle on their SSI rates (Keenan et al. 2015). They found
that ERP implementation was associated with a reduced
LOS (8.3 vs. 6.6 days, p < 0.01), but a reduction in SSI was
not observed until after implementation of the bundle,
when their SSI rate decreased from 16.1 to 6.3% (p < 0.01),
and their sepsis rate fell from 11.2 to 1.8% (p < 0.01). They
also observed the ERP + bundle resulted in a decrease in
average cost of admission, from $31,926 to $22,044 (p <
0.01). Given the strength of these and a number of other
studies, the commonality and costs associated with SSI,
and the lack of any detrimental effect of the bundle, we
recommend that infection prevention bundles be routinely
implemented as part of ERP (Thiele et al. 2015).
Combined oral antibiotic and mechanical bowel prep
We recommend routine use of a combined isosmotic
mechanical bowel prep (MBP) with oral antibiotics (OA)
before elective colorectal surgery.
Mechanical bowel prep alone
We do not recommend use of MBP without concurrent
oral antibiotics before elective colorectal surgery.
In this section we will focus on whether or not pre-
operative bowel preparation, including both MBP and
OA, are efficacious in preventing SSI after CRS. We
recognize this is a highly controversial topic with diver-
gent practices and opinions between the USA and Eur-
ope. At least some of the controversy on this topic
results from confusion over the findings of two separate
Cochrane group analyses, published within 1 year of
each other (reviewed below). In the following sections,
we will review the best available literature in an attempt
to provide clarity to this topic.
It is imperative to note that all bowel preparations are
not the same. MBPs are defined as oral preparations
given prior to surgery as a cathartic with the intention of
clearing out solid stool; this does not include transanal
enemas as, although they are given for the intention of
clearing out stool, they are not given orally and are of
more limited utility. On the other hand, OAs given
often, but not always with MBPs, are intended to
decrease the intraluminal bacterial concentration.
Historically, as early as 1973, the Nichols-Condon bowel
prep was both a MBP and OA regimen (neomycin and
erythromycin) and, at the time, reduced the SSI rate
from 43 to 9% (Nichols et al. 1973). When interpreting
the literature or your own institutional practice patterns,
it is imperative to discern whether MBP was used with
or without OA.
Cochrane #1: intravenous (IV) and oral antibiotics In
2009, Nelson et al. reported on the efficacy of both IV
and oral antibiotics in CRS (Nelson et al. 2009). They
found that a combined oral and IV antibiotic prophylaxis
was associated with a lower rate of SSIs (RR 0.55, 95%
confidence interval [C.I.] 0.41–0.74; RR 0.34, 95% C.I.
0.13–0.87) compared to either IV alone or OA alone, re-
spectively. Their conclusions were that both IV and oral
antibiotics should be given routinely and can reduce SSIs
by 75%. It is important to note that each of the studies
evaluating the use of OA included a MBP. Therefore, it
is unknown whether or not OA in the absence of a MBP
is efficacious at reducing SSI.
Cochrane #2: mechanical bowel prep (MBP) alone
However, in 2011, Guenaga et al. reported on the effi-
cacy of MBPs in >5000 patients (Guenaga et al. 2011).
That meta-analysis, which compared MBP to no MBP,
and also MBP to rectal enemas, found that there was no
increase in complications associated with omission of
the MBP. Their conclusion was essentially that MBP
could be safely omitted. These findings were echoed by
a similar meta-analysis also published in 2011 (Bellows
et al. 2011). Other earlier meta-analyses which had simi-
lar findings included Pineda et al. and Slim et al. (Pineda
et al. 2008; Slim et al. 2009). Nicholson reported a large
retrospective cohort study 2011 with congruent findings
and recommendations (Nicholson et al. 2011). Note the
majority of studies in this review compared MBP alone
in the absence of OA to the omission of the MBP.
Obviously, the problem with the two different
Cochrane meta-analyses is that they are asking different
questions. Nelson et al. (Nelson et al. 2010) demon-
strates the efficacy of OA (in the presence of a MBP) in
addition to IV antibiotics for surgical prophylaxis while
Guenaga et al. (Guenaga et al. 2011) demonstrated that
a MBP in the absence of OA is not effective in reducing
SSI and can be safely omitted. The finding that MBP
alone does not decrease SSI's is not surprising, as a
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mechanical cleanse in the absence of OA results in
bacteria-laden liquid stool that is more likely to contam-
inate the surgical field. In addition, the majority of ran-
domized data upon which the practice of routinely
omitting bowel preps is based upon did not use combin-
ation preps, only MBP without OA.
More recently, in the USA, real-world studies have
attempted to definitely answer the question of whether
the combination of MBP and OA is more efficacious
than MBP without OA using big data. In 2012, Cannon
et al. reported a Veterans Affairs SCIP report of 9440
patients (Cannon et al. 2012). They found that MBP
(without OA) compared to no MBP (also without OA)
had a similarly high rate of SSI (20 vs. 18.1%) but that
OA alone resulted in a 67% decrease in SSIs (odds ratio
[OR] 0.33, 95% C.I. 0.21–0.5) and OA plus MBP resulted
in a 57% reduction in SSI (OR 0.43, 95% C.I. 0.34–0.55);
furthermore, they reported a statistically significant
strong inverse correlation (r2 = 0.27, p < 0.0001) between
individual hospitals’ OA rate and their SSI rate (Fig. 2).
In a follow-up analysis, that group found that OA use
was associated with a shorter postoperative LOS and
also lower 30-day readmission rates, mostly due to lower
rates of infectious complications (Toneva et al. 2013).
Subsequently, in 2015, in another real-world, big data
study, Kiran et al. reported a NSQIP study examining
>8000 patients and found that the group that had both
MBP with OA had a nearly 50% reduction in SSI, anasto-
motic leak, end even ileus (Kiran et al. 2015). This, al-
though a retrospective study of a prospectively maintained
clinical database, likely represents the topical best-single
study to date. In this light, MBP alone and no MBP are
equally inferior to combined OA and MBP (Fig. 3).
In summary, the use of a MBP alone in the absence of
OA cannot be recommended. However, the data suggest
that a combination of a MBP and OA is associated with
the lowest rate of infectious morbidity following CRS.
This distinction cannot be overemphasized, as the
majority of surgeons in the USA are using a MBP in the
absence of OA (Kiran et al. 2015; Moghadamyeghaneh
et al. 2015; Morris et al. 2015).
Isosmotic vs. hyperosmotic mechanical bowel preps
We recommend against the use of hyperosmotic bowel
prep solutions before elective colorectal surgery.
It is a common misconception that all MBPs inevitably
lead to dehydration and detrimental physiologic effects.
This is because many of the phosphate-based solutions
initially described in MBP were hyperosmotic solutions.
Hyperosmotic preparations (e.g., magnesium citrate, so-
dium phosphate) exert an osmotic effect, drawing fluid
into the bowel. As a result, hyperosmotic solutions are
much smaller in volume and typically more palatable to
patients. Although better tolerated, these solutions cause
significant fluid and electrolyte shifts and can be associ-
ated with renal damage (Holte et al. 2004; Ackland et al.
2008; Ackland et al. 2004). For this reason, the use of
hyperosmotic bowel preparation solutions within an ERP
is not recommended. Table 3 describes the clinical char-
acteristics of various MBP regimens.
As opposed to the hyperosmotic preparations, the
isosmotic solutions of current standard MBP regimens
are much better tolerated. Currently, the most widely
used cathartic for MBP in the USA is polyethylene glycol
(PEG), an isosmotic electrolyte lavage solution that is
standardly administered in a 4-L preparation. Because it
is a high-molecular weight, non-absorbable polymer, it
passes through the GI tract without net absorption or
secretion, thereby avoiding significant fluid and electro-
lyte shifts. The most common side effects associated
with PEG solutions are nausea and vomiting, which affect
4–17% of patients on average (Dahabreh et al. 2015).
Large-volume PEG preparations include GoLYTELY®,
Colyte®, NuLytely®, and TriLyte®. Patients frequently
complain about the large volume and salty taste of
the solution. As a result, low-volume PEG (32–64 oz,
Fig. 2 Facility-level surgical site infection rates by oral antibiotic administration. SSI surgical site infection, OA oral antibiotic. Reproduced with
permission from Cannon et al., Dis Colon Rectum 2012; 55: 1160–1166
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i.e., 1–2 L) preparations combined with other cathar-
tic agents have been developed including MiraLax®,
HalfLytely®, MoviPrep®, and BiPeglyte®. While they
seem to be effective for colonoscopy, there are few
data specifically evaluating the use of these low-
volume preparations specific to CRS.
As previously mentioned, isosmotic solutions such as
PEG do not share the deleterious physiologic properties as
the hyperosmotic solutions. Hendry et al. (Hendry et al.
2008) performed a feasibility study combining the use of
oral carbohydrate loading with a MBP in patients under-
going elective left colon and rectal resections, demonstrat-
ing that 84% of patients tolerate the preoperative oral
fluid/carbohydrate loading in conjunction with the MBP
with no untoward effects. Similarly, Thiele et al. (Thiele et
al. 2015) demonstrated that a MBP using GoLytely® and
OA could effectively be incorporated into a successful
ERP. Through implementation of an ERP utilizing a MBP
with OA, fluid administration was reduced by 1885 mL
during surgery and by 4591 mL over the entire
hospitalization resulting in a 2.2-day reduction in LOS
and a reduction in overall complications by 48.8% (p <
0.0001) including a significant reduction in SSI.
Prevention of pneumonia after CRS
Risk assessment
We suggest preoperative risk assessment for aspiration
and pneumonia be routinely implemented in colorectal
ERPs.
Postoperative pneumonia (PNA) can be broadly classi-
fied into two categories: non-aspiration PNA and
aspiration PNA. Non-aspiration PNA can be community-
acquired PNA (CAP) that occasionally will be recognized
immediately prior to surgery and appropriately result in
cancelation of general anesthesia. Occasionally, “walking
PNA” may go unrecognized and not be diagnosed until
postoperatively and is very difficult to differentiate from
nosocomial-associated pneumonia (NAP). Nosocomial
PNA, a HAC, for postsurgical patients can be further clas-
sified as ventilator-associated PNA (VAP) in those who
develop it within 48–72 h of endotracheal intubation.
In the setting of ERP, prevention of PNA starts with
preoperative risk assessment (Gallart and Canet 2015).
The ERP professionals must recognize risk factors for
both PNA and for aspiration which are considered
pulmonary complications (Yang et al. 2015; Arozullah et
al. 2000). Risk factors for PNA include active smoker,
former smoker, active pulmonary disease, decreased ex-
ercise capacity and/or functional dependency, advanced
age, supra-umbilical incision, narcotic use (via respira-
tory depression), neuroleptic medications, and dementia.
Ideally, these risk factors should be identified preopera-
tively and reversible risk factors addressed as the
situation allows.
Fig. 3 Postoperative complications according to type of bowel preparation. Black star = statistical significance, p < 0.0001. Adapted with
permission from Kiran et al., Ann Surg 2015;262:416 24
Table 3 Risks and benefits of various bowel prep solutions
Name Advantages Disadvantages
Polyethylene
glycol (PEG)
Safe Large volume, poor taste
Sulfate-free PEG Safe, better taste Large volume
Low-volume PEG
and bisacodyl
Safe, lower
volume (2 vs. 4 L)
Still large volume
Sodium phosphate Small volume Electrolyte and fluid shifts,
caution in cardiac/liver/renal
dysfunction/elderly/dehydrated
Magnesium citrate Low volume Electrolyte and fluid shifts
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For example, it is completely ethical for a patient requiring
elective sigmoid resection for recurrent uncomplicated di-
verticular disease to be required to quit smoking for a mini-
mum of 6 weeks preoperatively as smoking is a known risk
factor for anastomotic leak (Midura et al. 2015). The recom-
mendation for 6 weeks is based on plastic surgery recom-
mendations and includes a mandatory 6-week period of
nicotine abstinence and preoperative testing of plasma or
urinary cotinine, a nicotine metabolite (Reinbold et al.
2015). However, for smoking as a risk factor for pulmonary
complications, it is generally agreed that any period of cessa-
tion can help reduce pulmonary complications, with “the
longer, the better” being preferable.
A more extreme example would be a patient awaiting
Hartmann’s colostomy closure who also has a giant
ventral hernia requiring abdominal wall reconstruction
with component separation; in this example, the compli-
cation rate is so high and the magnitude of required heal-
ing so large that smoking cessation is obligatory. On the
other hand, expectation of smoking cessation (or weight
loss) may be unreasonable in a colorectal cancer patient.
Preoperatively, all CRS ERP patients should receive edu-
cational instruction regarding the expectation and motiv-
ation for the use of lung function-maintaining adjuncts
such as epidural catheters, multimodal non-opioid anal-
gesia, incentive spirometry (IS), coughing, and chest
physiotherapy in prevention of PNA and other pulmonary
complications. All CRS ERP patients should receive an IS
and instructions, ideally preoperatively, or as soon as pos-
sible postoperatively (day of surgery upon arrival to PACU
or the floor). Some centers provide a pillow with an insti-
tutional logo for splinting, while others instruct their pa-
tients to bring a small pillow with them from home for
this purpose. Finally, when NAP does occur, best available
antibiotic regimens should be followed according to infec-
tious disease guidelines and institutional antibiograms.
The other major source of major pulmonary morbidity
is respiratory aspiration of gastrointestinal contents, which
can be a lethal complication. The relationship between
aspiration of gastric contents and aspiration pneumonitis,
is well known. The risk factors for aspiration are summa-
rized in Table 4. Awareness of the risk factors for aspir-
ation is the first step in its prevention.
Once aspiration has occurred, management should be
directed towards supportive modalities and optimizing
end organ perfusion. Tracheal suctioning prior to
positive pressure ventilation is helpful in preventing as-
pirated material from damaging the respiratory system.
Because aspiration is more likely to affect the right lung
secondary to the more vertical angle of the right main
bronchus, early chest X-rays will show consolidation in
the right side in up to 75% of cases and early bronchos-
copy may help prevent distal atelectasis if particulate
matter can be aspirated. Aspiration may lead to a variety
of clinical conditions, including chemical pneumonitis,
bacterial PNA, adult respiratory distress syndrome
(ARDS), and complete cardiopulmonary collapse and
death. Mechanical ventilation may be required for pro-
longed periods. The main controversies surrounding
treatment decisions involve the decision to use antibi-
otics and steroids. Antibiotics should only be used if
PNA develops, as early antibiotics may lead to the
selection of virulent bacteria including Pseudomonas.
There is no evidence that using steroids either reduces
mortality or improves outcome (Muscedere et al. 2008).
Optimizing lung function
We recommend routine use of low tidal volumes, lung
recruitment, and other lung-protective strategies during
elective colorectal surgery.
Table 4 Risk factors for aspiration (Zargar-Shoshtari et al. 2009)
Patient factors (a) Full stomach
· Emergency surgery
· Inadequate fasting time
· Gastrointestinal obstruction
(b) Delayed gastric emptying
· Systemic diseases, i.e., diabetes mellitus,
chronic kidney disease
· Recent trauma
· Opioids
· Raised intracranial pressure
· Previous gastrointestinal surgery
· Pregnancy (including active labor)
(c) Incompetent lower esophageal sphincter
· Hiatus hernia
· Recurrent regurgitation
· Dyspepsia
· Previous upper gastrointestinal surgery
· Pregnancy
(d) Esophageal diseases
· Previous gastrointestinal surgery
· Morbid obesity
Surgical factors Upper gastrointestinal surgery
· Lithotomy or head down position
· Laparoscopy
· Cholecystectomy
Anesthetic factors Light anesthesia
· Supraglottic airways
· Positive pressure ventilation
· Length of surgery >2 h
· Difficult airway
Device factors First-generation supraglottic airway devices
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Utilizing protective ventilation strategies with low tidal
volumes, optimal amounts of positive end-expiratory
pressure (PEEP), and individualized ventilation therapy
(which may include spontaneous breathing) have shown
improved outcomes for surgical patients.
It has been established in ARDS that lung-protective
strategies are best practice, but for elective surgery major
abdominal surgery, the role of lung-protective ventilation,
although well studied, has had slower adoption and
penetration. It is defined as “the delivery of a tidal volume
between 6 and 8 ml/kg/predicted body weight, a peak
pressure of less than 30 cmH2O, and the use of positive
end expiratory pressure of 6-8 cmH2O” (Patel et al. 2016).
In a meta-analysis of 15 studies, the authors found a dose-
response curve between the size of tidal volume and
pulmonary complications (Serpa Neto et al. 2015).
In terms of lung recruitment and PEEP, individualizing
PEEP therapy based on respiratory mechanics may reduce
the incidence of over-distension and cyclic atelectasis,
increase aerated lung available for tidal insufflation, and
promote more uniform distribution of mechanical strain
(Cressoni et al. 2014). Several mechanics-based PEEP
titration strategies have been proposed, including highest
respiratory system compliance (Kacmarek et al. 2016),
esophageal pressure-guided titration (Talmor et al. 2008),
stress index (Grasso et al. 2007), ExPress PEEP (Mercat et
al. 2008), and pressure-volume curve lower inflection
point (Pflex) (Amato et al. 1998).
There are two concepts for lung recruitment. First,
PEEP-maintained lung recruitment refers to the benefit
of PEEP to maintain open, at end expiration, the lung
parenchyma that has been recruited during the inspir-
ation phase, thus reducing the incidence and severity of
atelectasis (Cressoni et al. 2014). The second concept of
lung recruitment refers to actual positive pressure that is
given to the patient to open up collapsed alveoli. This
type of lung recruitment has been advised to be at
40 cmH2O for a duration of 40 s (Meade et al. 2008). It
occurs in response to hypoxia on current ventilator
settings when atelectasis is believed to be the underlying
etiology. Thus, there is no set time interval as to how
often.
The role of the driving pressure, which is the difference
between the plateau pressure and the level of PEEP was
studied in a meta-analysis which suggested that driving
pressure was associated with the development of postop-
erative pulmonary complications (odds ratio [OR] for one
unit increase of driving pressure 1.16, 95% C.I. 1.13–1.19;
p < 0.0001), whereas no association was seen for tidal
volume (1.05, 0.98–1.13; p = 0.179) (Neto et al. 2016).
Finally, spontaneous breathing may be beneficial for
patients because this promotes alveolar recruitment, stim-
ulates surfactant production, and attenuates diaphragm
disuse atrophy, while avoiding risks of heavy sedation and
neuromuscular blockade. However, because spontaneous
breathing is not possible in a paralyzed patient undergoing
major abdominal surgery, “noisy ventilation,” where differ-
ent tidal volumes are provided on a breath-to-breath basis
(with a coefficient variation of 40%), may be helpful
(Spieth et al. 2009). Of note, noisy breathing effort also
can lead to high tidal volumes, breath stacking dys-
synchrony, regional over-distension, and tidal recruitment,
potentiating lung injury risk (Yoshida et al. 2013). Thus,
therapy must be individualized based on the patient’s
specific needs.
Nasogastric tubes and early postoperative feeding
Nasogastric tube use
We recommend against routine use of postoperative
nasogastric tube (NGT) drainage after elective colorectal
surgery.
Historically, NGTs were used for decompression to
theoretically “rest” the anastomosis in the early postop-
erative period and diminish the risk of anastomotic leak-
age. The presence of an NGT has clearly been identified
as a risk factor for aspiration pneumonia, which is asso-
ciated with significant morbidity and mortality (Kirby et
al. 1995; Langmore et al. 1998; Gomes et al. 2003). In
addition, a large Cochrane review encompassing over
5000 patients demonstrated that the routine use of a
NGT after abdominal surgery is associated with de-
layed return of bowel function, increased pulmonary
complications, and no difference in anastomotic leak
(Nelson et al. 2007). Therefore, the routine use of
NGT drainage for decompression after elective CRS is
not recommended.
Every attempt should be made to encourage early
postoperative oral feeding, which has been demonstrated
to be safe and effective following elective CRS (Lewis et
al. 2008). Historically, the concern has been that early
postoperative feeding would lead to increased rates of
aspiration. However, this has not been demonstrated in
the literature. In 2003, DiFronzo reported a randomized
controlled trial (RCT) on the safety of early feeding in
elderly patients who had colon surgery. In this trial of 87
patients over the age of 70, there were no occurrences of
PNA (DiFronzo et al. 2003). In 2007, Han-Geurts et al.
reported a RCT of 128 patients having elective colorectal
or abdominal aorta surgery. Early feeding was not
associated with an increased rate of postoperative com-
plications, although the NGT reinsertion rate was 20%
in the early feeding group vs. 10% in the nil per os
(NPO) group (Han-Geurts et al. 2007). There was no
difference in the rate of PNA (7 vs. 10%, p = 0.76).
Finally, a meta-analysis on this topic of eight studies
encompassing 423 patients in the early feeding arm and
426 in the NPO arm found there was no significant dif-
ference in the rate of PNA (Andersen et al. 2006).
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Alternatively, nasoenteric tubes are occasionally used
for enteral feeding in the postoperative period, particu-
larly in patients with significant preoperative malnutri-
tion. There is also evidence that the presence of a
nasoenteric feeding tube is associated with colonization
and aspiration of pharyngeal secretions and gastric con-
tents leading to a high incidence of Gram-negative
pneumonia in patients on enteral nutrition (Gomes et al.
2003). Efforts to feed the patient orally should be
exhausted prior to placement of a nasoenteric tube for
feeding in the postoperative period. However, a post-
pyloric tube is one of the options when a patient does
require enteral nutrition (or a percutaneous gastrostomy
tube with a post-pyloric extension [“drain me, feed me”]
or a percutaneous jejunostomy tube), to reduce the risk
of aspiration in the fresh postoperative but critically ill
or otherwise unable to take per os (PO) patient. In the
colorectal population, bowel dysfunction occurs in ap-
proximately 20% and often results in the need for total
parenteral nutrition.
Recognizing ileus
We recommend early recognition and treatment of postoper-
ative ileus. This includes NGT insertion when appropriate.
The prevention, recognition, and treatment of ileus are
beyond the scope of this infection prevention article and
will be fully addressed in the future in the POQI-2 con-
ference. It is clear that avoidance of prophylactic NGTs
and early feeding are both associated with a lower mor-
tality (Lewis et al. 2008; DiFronzo et al. 2003; Han-
Geurts et al. 2007; Andersen et al. 2006). Although the
routine use of NGT decompression is not recom-
mended, this should not be misinterpreted to mean that
NGT decompression should not be utilized for the
treatment of an ileus. On the contrary, early recognition
of ileus with placement of an NGT is critical to prevent-
ing the development of a lethal aspiration pneumonitis.
ERP has been shown to reduce the rates of ileus but
does not completely obviate the risk. Any patient with
abdominal distention, bilious emesis, and an enlarged
gastric bubble on abdominal radiograph requires evalu-
ation by a physician for NGT placement. This is particu-
larly true of elderly patients who are vulnerable to
aspiration events. It is critical that the ERP team be vigi-
lant in recognizing and treating ileus and bowel obstruc-
tion with nasogastric decompression as needed.
Preventing urinary tract infection
Optimal urinary catheter use
We recommend early urinary catheter removal (within
24 h) after elective colon surgery. Timing of catheter re-
moval after pelvic surgery should be left to the surgeon’s
discretion.
Managing early postoperative urinary retention
We suggest that for patients who fail trial of void, clean
intermittent catheterization for 24 h is associated with a
lower rate of urinary tract infection (UTI).
UTIs and postoperative urinary retention (POUR) are
both recognized complications of CRS, each occurring
in 2–3% of all cases but in substantially higher rates in
high-risk patients (Halabi et al. 2014; Kin et al. 2013).
Risk factors for both UTI and POUR are shown Fig. 4.
Risk for UTI or POUR should guide clinical decision-
making for bladder catheterization (Fig. 5). Catheter-
associated urinary tract infection (CAUTI) is the most
common healthcare-associated infection worldwide
(Tambyah 2004). A study in 2565 US hospitals involving
Fig. 4 Risk factors for both UTI and POUR
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35,904 Medicare inpatients undergoing major surgery in
2001 found that 85% of patients had perioperative in-
dwelling urinary catheters. Of these, 50% had catheters
for longer than 2 days postoperatively. These patients
were twice as likely to develop UTIs than patients with
catheterization of 2 days or less. In multivariate analyses,
a postoperative catheterization longer than 2 days was
associated with an increased likelihood of in-hospital
UTIs (hazard ratio, 1.21; 95% confidence interval [C.I.]
1.04–1.41).(Wald et al. 2008)
However, early removal of indwelling catheters is a
recognized contributor to POUR (Baldini et al. 2009). In
a prospective observational study in 143 patients, cathe-
ters were removed on postoperative day 1 for abdominal
surgeries and day 3 for pelvic surgeries. The overall
urinary retention rate was 22.4%, and 4.9% developed
UTI (Kin et al. 2013). The highest rates of POUR were
observed with laparoscopic cases. Spinal or epidural an-
algesia may increase risk for POUR (Baldini et al. 2009).
However, this finding has not been universal. In a US
Nationwide Inpatient Sample study of 191,576
laparoscopic colorectal surgeries performed between
2002 and 2010, a 1:4 case-matched analysis was per-
formed, matching for patient demographic characteris-
tics, hospital setting, indications, and procedure type.
Epidural analgesia was used in 4102 cases (2.14%) but
was not associated with an increased incidence of
urinary retention. Conversely, there was a higher rate of
UTI (OR = 1.81; p = 0.05) (Halabi et al. 2014). Given the
retrospective nature of this analysis, it was not possible
to control for catheter use and it seems likely there is a
trade-off between POUR and UTI based on duration of
indwelling catheterization.
One potential contraindication to early catheter re-
moval is in patients known to be high risk for oliguria,
which unmonitored, can progress to frank AKI (Drolet
et al. 2010; Causey et al. 2011). These specific patients
include patients with known CRI, baseline abnormal
serum creatinine, creatinine clearance <60, vasculopaths,
ICU patients, patients receiving multiple nephrotoxic
medications, and those at increased risk for contrast-
induced nephropathy (often a transfer patient whose
“outside” CT scan is inadequate and repeating would
result in an alteration of the surgical plan). Clearly, the
average colectomy patient has zero to one of these, and
for the majority of colectomy enhanced recovery
patients, the catheters should be removed <24 h after
placement. This include s removal in the OR for very
low risk patients (ex. healthy female, right colectomy).
Thus, we recommend individualization of the decision
to use and maintain bladder catheterization based on
risk for either POUR or UTI (Fig. 5). As the risks for
UTI exceed the risk for POUR, consideration should be
given to shorter duration of catheterization. In general,
the goal should be to remove catheters by 48 h, as the
benefits of continued catheterization are unlikely to ex-
ceed the risks after this point. We recommend clean
intermittent catheterization to manage POUR after 48 h.
Importantly, various risk mitigation strategies for both
CAUTI and POUR have been studied.
Fig. 5 Risks and benefits of urinary catheters
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Implementation of a “care bundle” including the for-
mation of a multidisciplinary CAUTI reduction task
force, formal data collection, staff education for best
practices, and new electronic order sets with decision
support achieved a reduction in the infection rate per
1000 catheter days from 5.4 to 1.5. Cost savings per
1000 catheter days (±20%) were $4501 ($3600–$5401)
(Sutherland et al. 2015). ERPs themselves may reduce
UTI (Zargar-Shoshtari et al. 2009; Miller et al. 2014).
A RCT in 239 patients undergoing elective abdominal sur-
gery examined the effect of three doses of trimethoprim-
sulfamethoxazole started at urinary catheter removal on
UTI. Patients who received antibiotic prophylaxis showed
significantly fewer UTIs (5/103, 4.9%) than those without
prophylaxis (22/102, 21.6%), p < 0.001 (Pfefferkorn et al.
2009). Importantly though, this strategy did not reduce UTI
rates to levels seen with early catheter removal but could be
an effective strategy for patients requiring prolonged
catheterization. Other approaches include novel catheter
technology such as silver-impregnated Foley catheters
(Leuck et al. 2015).
Strategies have also been examined to reduce POUR.
In a retrospective analysis of all men undergoing pelvic
surgery between 2004 and 2013 (n = 185), patients given
0.4 mg of tamsulosin 3 days prior and after surgery at
the discretion of the surgeon had lower rates of urinary
retention (6.7 vs. 25%; p = 0.03).The authors also found
that distal rectal cancer was associated with POUR and
tamsulosin may be particularly helpful in that subgroup
(Poylin et al. 2015).
Preventing CLABSI
Avoid routine central line use
We do not recommend routine central line use during
elective colorectal surgery.
Earliest possible removal of central lines
We recommend that if a central line use is used, it
should be removed as soon as possible.
For the purposes of this paper, we define central ven-
ous access as placement of a catheter directly into a ven-
ous great vessel. The venous great vessels include the
superior vena cava, inferior vena cava, internal jugular
veins, subclavian veins, and common femoral veins.
Central venous catheters (CVCs) are integral to the
care of critically ill patients. CVCs traditionally have
been used for three broad purposes: (1) reliable large-
bore venous access for fluid and blood product infusion,
(2) infusion of medications, and (3) measuring central
venous pressures (CVPs). Unfortunately, CVCs are also
the leading cause of healthcare-associated bloodstream
infections (BSIs) and are frequently implicated in life-
threatening illnesses.
Of the approximately 249,000 BSIs that have been
shown to occur in US hospitals each year, 80,000 (32.2%)
were found in intensive care unit (ICU) settings (Mermel
2000). The economic burden of central line-associated
bloodstream infections (CLABSIs) is also quite
significant. A single CLABSI episode independently in-
creases length of hospitalization from 7 to 21 days, at an
attributable cost of about $32,000 per patient (Stevens et
al. 2014). Furthermore, the annual national cost of car-
ing for patients who develop CLABSI is estimated to
range from $0.67 to $2.68 billion (Shah et al. 2013).
CLABSIs are potentially preventable through the use of
evidence-based practices (Rosendal et al. 2014). We do not
recommend the routine use of central venous catheters for
CRS, which is not typically associated with significant blood
loss or frequent intraoperative complications. Fluids and
blood products can be administered peripherally through
large-bore (i.e. 16 gauge) IV lines. Furthermore, most drugs
can be infused peripherally as well. Those agents needing
centrally mediated infusion (i.e., high-dose norepinephrine)
would necessitate CVC placement. A risk stratification as-
sessment should occur preoperatively to determine the like-
lihood of such an infusion intraoperatively, prior to insertion
of a CVC (Fig. 6). In terms of hemodynamic monitoring, we
do not recommend routine monitoring of the CVP because
of the unreliable measurement of CVP in guiding fluid
therapy, especially in the presence of increased abdominal
pressure and Trendelenburg positioning (Rosendal et al.
2014; Gottlieb and Hunter 2016; Eskesen et al. 2016). Thus,
placement of a CVC for monitoring CVP is not recom-
mended. Instead, more modern approaches such as esopha-
geal Doppler, and pulse pressure variation, should be used
to guide fluid management, ideally with goal-directed ther-
apy or a zero-balance approach.
Finally, should a CVC be placed, prompt attention
should be directed in the immediate postoperative
period to determine if there is a continued need for a
CVC in the patient. Prompt removal of the CVC and
further care via peripheral intravenous lines should be
attempted when possible. If patients are discharged with
a PICC line, for ongoing IV fluids or TPN, professionals
should be aware not only of the risk of infection but of
the upper extremity deep vein thrombosis.
Future directions: prevention of postop SSIs
A number of issues regarding optimal bowel preps re-
main. Regarding OA with or without MBP, since the
bulk of stool weight is bacteria, it is broadly assumed
that the efficacy of OA is partly dependent on the mech-
anical cleansing. To the best of our knowledge, other
than the VA-SCIP study mentioned above, few if any
studied to date examined the question of OA with or
without MBP. The question of OA without MBP is ripe
for basic-science, translational, or clinical research.
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In addition, given the emetogenicity of the standard
Nichols-Condon prep (2 g of neomycin and 2 g of
metronidazole PO twice), more modern, alternative anti-
biotic preps are sorely needed. Several interesting studies
from Scandinavia used tinidazole, a better tolerated al-
ternative to metronidazole, and doxycycline, to effect
low SSI rates (Giercksky et al. 1982; Ofstad et al. 1980).
Another interesting, yet unstudied, potential alternative
OA bowel prep is rifaximin, a non-absorbable form of ri-
fampin, which has proven efficacy in targeting both GI
aerobes and anaerobes (Huang and DuPont 2005; Ojetti
et al. 2009). Finally, there is a new FDA-approved prod-
uct using PEG-infused bars and beverages that allows
patients to prep without fasting, which has successfully
completed a phase 2 clinical trial for patients undergoing
colonoscopy; ultimately, this may prove to be a more
tolerable preoperative MBP (personal communication,
Dr. Corey Siegel MD).
As stated above, the classic teaching is that leaks are
caused mostly by vascular insufficiency, sub-optimal
surgical technique, or poor surgical tissues. However,
high-quality translational research has emerged suggesting
that an infectious etiology secondary to high-collagenase-
producing bacteria such as Pseudomonas and Entero-
coccus may contribute to anastomotic leak (Shogan et al.
2013; Olivas et al. 2012). This is particularly important as
these bacteria may not be covered by a second-generation
cephalosporin + metronidazole, which is commonly used
for surgical prophylaxis (Alexander et al. 2011). The most
recent addition to this growing body of literature suggests
that in animals, morphine binding in the bowel is associ-
ated with Enterococcus colonization, which dovetails with
ERPs and multimodal analgesia (Shakhsheer et al. 2016).
Reportedly, a large multicenter study using either pipera-
cillin/tazobactam or levofloxacin is being undertaken to
address this issue.
Another recent development in preventing anasto-
motic leaks is the use of indocyanine green (ICG) and
near-infrared laparoscopes to assess anastomotic perfu-
sion in real time (Jafari et al. 2015). This results in anas-
tomotic revision in roughly 10% of cases and is a very
promising adjunct to reduce anastomotic leak rates. As
these units become more widely used, hopefully it will
prevent anastomotic leaks and downstream infections.
Conclusions
In conclusion, although infections are the single most
common complication after CRS, ERPs can help mitigate
their occurrence and reduce their incidence by avoiding
them altogether or hopefully at least reduce their severity
and downstream sequelae. The intention of this paper,
and the POQI-1 conference, was to develop expert con-
sensus on various target topics. Rather than a prescription,
users should use these recommendations as a menu of in-
terventions which should be shared with like-minded
progressive, best available evidence-practicing physicians,
knowing that individual recommendation of bundle elem-
ent may or may not be suitable, applicable, acceptable, or
Fig. 6 Central line use in colorectal surgery
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affordable at their own institutions. Over the next several
years, readers should expect annual POQI papers and
POQI-2, which will address ileus among other topics, will
be a product of those endeavors.
Abbreviations
ARDS: Acute respiratory distress syndrome; BSI: Bloodstream infection;
CI: Confidence interval; CLABSI: Central line-associated bloodstream infection;
CRS: Colorectal surgery; CVC: Central venous catheter; CVP: Central venous pressure;
ERP: Enhanced recovery pathway; FDA: US Food and Drug Administration;
GI: Gastrointestinal; HAC: Hospital-acquired condition; ICG: Indocyanine green;
IS: Incentive spirometry; IV: Intravenous; MBP: Mechanical bowel prep;
NAP: Nosocomial-associated pneumonia; NGT: Nasogastric tube; NPO: Nil per os;
NSQIP: National Surgery Quality Improvement Program; OA: Oral antibiotic;
OR: Odds ratio; PACU: Post-anesthesia care unit; PEG: Polyethylene glycol;
PNA: Postoperative pneumonia; PO: Per os; POD: Postoperative day;
POQI: Perioperative Quality Initiative; POUR: Postoperative urinary retention;
RCT: Randomized controlled trial; SSI: Surgical site infection; US: United States;
UTI: Urinary tract infection; VAP: Ventilator-associated pneumonia
Acknowledgements
The Perioperative Quality Initiative (POQI) I Workgroup includes Timothy E. Miller,
Andrew D. Shaw, Michael G. Mythen, Tong J. Gan, Matthew D. McEvoy,
Michael J. Scott, Deborah Gordon, Stuart Grant, Julie K.M. Thacker, Christopher L. Wu,
Robert H. Thiele, Karthik Raghunathan, CS Brudney, Dileep N. Lobo, Daniel Martin,
Anthony Senagore, Stefan D. Holubar, Traci Hedrick, John Kellum, Ruchir Gupta,
Mark Hamilton, S. Ramani Moonesinghe, Mike P.W. Grocott, Elliott Bennett-Guerrero,
Thomas J. Hopkins, Roberto Bergamaschi and Stuart McCluskey.
Funding
The POQI meeting received financial assistance from Baxter, Cheetah
Medical, Edwards Lifesciences, Mallinckrodt, and Pacira.
Availability of data and materials
N/A.
Authors’ contributions
All authors contributed to the development of this manuscript, agree to its
contents, and approved its final version.
Competing interests
SDH has received stipends for advisory board work: Mallinckrodt, Pacira, The
Medicines Co., and Trevena Inc., and royalties from PCI Communications for
editorial work on the ASER Guidebook. MG is National Specialty Lead for
Anaesthesia, Perioperative Medicine and Pain for the UK National Institute of
Health Research Clinical Research Network, serves on the Board and Research
Council member of the UK National Institute of Academic Anaesthesia, and is
an elected council member of the Royal College of Anaesthetists and an
elected board member of the UK Faculty of Intensive Care Medicine. MG serves
on the medical Advisory Board of Sphere Medical and has received honoraria
for speaking and/or travel expenses (last 5 years) from Edwards Lifesciences. TH
is a consultant for Cheetah Medical and Teleflex. TJG has received honoraria
from Edwards, Mallinckrodt, Merck, and Pacira. MGM is Smiths Medical Professor
of Anaesthesia and Critical Care UCL and a Consultant at UCLH. He is Director
of the UCL Centre for Anaesthesia and The UCL Discovery Lab and a resident PI
at the Institute of Spots Exercise and Health. He is a paid Consultant for
Edwards Lifesciences (via UCL Consulting and independently) and Deltex in the
USA. He was a National Clinical Advisor for the Department of Health Enhanced
Recovery Partnership until May 2013; stockholder and advisory board for
Medical Defence Technologies LLC—(“Gastrostim” patented); Director
Bloomsbury Innovation Group—a community interest company owned by
UCLH Charity; and Co-Inventor of “QUENCH” (fluid management system) IP
being exploited by UCL Business. MGM’s institution has also received charitable
donations and grants from Smiths Medical Endowment and Deltex Medical.
MGM was also co-author of the GIFTASUP guidelines on perioperative fluid
management; Editor in Chief of Perioperative Medicine; on the Editorial Board
of the BJA and Critical Care; a member of the Improving Surgical Outcomes
Group; Expert advisor to the NICE IV fluids guideline development group;
Chairman of the Board of The National Institute of Academic Anaesthesia; Co-
Director Xtreme Everest; and Co-Chair Evidence Based Perioperative Medicine
(EBPOM). ADS is a Consultant for Astute Medical and Edwards Lifesciences. He
is on the Scientific Advisory Board for Thrasos and Battelle and DSMB chair for
AM Pharma. TEM has received research funding from Edwards Lifesciences and
is a consultant for Edwards Lifesciences and Cheetah Medical.
Consent for publication
N/A.
Ethics approval and consent to participate
N/A.
POQI work groups
POQI I conference directors
 Timothy E Miller, Department of Anesthesiology, Duke University
Medical Center, NC, USA
 Andrew D Shaw, Department of Anesthesiology, Vanderbilt
University Medical Center, Nashville, TN, USA
 Michael G Mythen, Department of Anaesthesia, University College
London, London, UK
 Tong J Gan, Department of Anesthesiology, Stony Brook University
School of Medicine, NY, USA
Group A—analgesia
 Matthew D. McEvoy, Department of Anesthesiology, Vanderbilt
University Medical Center, Nashville, TN, USA (chair)
 Michael J. Scott, Department of Anaesthesia, Royal Surrey County
NHS Foundation Hospital, Surrey, UK (co-chair)
 Deborah Gordon, RN, Department of Anesthesiology and Pain
Medicine, University of Washington
 Stuart Grant, Department of Anesthesiology, Duke University
Medical Center, NC, USA
 Julie K.M. Thacker, Division of Advanced Oncologic and GI Surgery,
Duke University Medical Center, NC, USA
 Christopher L. Wu, Department of Anesthesiology, The Johns
Hopkins University School of Medicine, MD, USA
Group B—fluids
 Robert H. Thiele, Departments of Anesthesiology and Biomedical
Engineering, University of Virginia School of Medicine, VA, USA
(chair)
 Karthik Raghunathan, Department of Anesthesiology, Duke
University Medical Center, USA (co-chair)
 CS Brudney, Department of Anesthesiology, Duke University
Medical Center, USA
 Dileep N Lobo, Division of Gastrointestinal Surgery, Nottingham
University Hospitals and University of Nottingham, Nottingham, UK
 Dr. Daniel Martin, Royal free Perioperative Research Group, Royal
Free Hospital, London, UK
 Anthony Senagore, Department of Surgery, University of Texas-
Medical Branch at Galveston, Galveston, TX, USA
 Maxime Cannesson, Department of Anesthesiology and
Perioperative Medicine, University of California Los Angeles, CA,
USA
Group C—infection
 Stefan D Holubar, Department of Surgery, Dartmouth-Hitchcock
Medical Center, NH, USA (chair)
 Traci Hedrick, Department of Surgery, University of Virginia School
of Medicine, VA, USA (co-chair)
 John Kellum, Department of Critical Care Medicine, University of
Pittsburgh School of Medicine, Pittsburgh, PA, USA
 Ruchir Gupta, Department of Anesthesiology, Stony Brook
University School of Medicine, NY, USA
 Mark Hamilton, Department of Anaesthesia, St. George’s Hospital
and Medical School, London, UK
Holubar et al. Perioperative Medicine  (2017) 6:4 Page 15 of 18
Group D—outcomes
 S. Ramani Moonesinghe, Department of Anaesthesia, University
College London, London, UK (chair)
 Mike PW Grocott, Department of Anesthesia and Critical Care
Medicine, University of Southampton, UK (co-chair)
 Elliott Bennett-Guerrero, Department of Anesthesiology, Stony
Brook University School of Medicine, NY, USA
 Thomas J Hopkins, Department of Anesthesiology, Duke University
Medical Center, NC, USA
 Roberto Bergamaschi, Department of Surgery, Stony Brook
University School of Medicine, NY, USA
 Stuart McCluskey, Department of Anesthesia, University of Toronto,
ON, Canada
Author details
1Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH,
USA. 2Department of Surgery, University of Virginia Health System,
Charlottesville, VA, USA. 3Department of Anesthesiology, Stony Brook School
of Medicine, Stony Brook, NY, USA. 4Department of Critical Care Medicine,
University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 5Department of
Intensive Care Medicine and Anaesthesia, St. George’s Hospital and Medical
School, London, UK. 6Department of Anesthesia, UCL/UCLH National Institute
of Health Research Biomedical Research Centre, London, UK. 7Department of
Anesthesiology, Vanderbilt University, Nashville, TN, USA. 8Department of
Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Received: 29 September 2016 Accepted: 11 January 2017
References
Ackland GL, Singh-Ranger D, Fox S, et al. Assessment of preoperative fluid
depletion using bioimpedance analysis. Br J Anaesth. 2004;92(1):134–6.
Ackland GL, Harrington J, Downie P, et al. Dehydration induced by bowel
preparation in older adults does not result in cognitive dysfunction. Anesth
Analg. 2008;106(3):924–9. doi:10.1213/ane.0b013e3181615247.
tableofcontents.
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control
of surgical site infections. Ann Surg. 2011;253(6):1082–93. doi:10.1097/SLA.
0b013e31821175f8.
Amato M, Barbas C, Medeiros DM, et al. Effect of a protective-ventilation strategy
on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;
338(6):347–54. doi:10.1056/NEJM199802053380602.
Andersen HK, Lewis SJ, Thomas S. Early enteral nutrition within 24h of colorectal
surgery versus later commencement of feeding for postoperative
complications. Cochrane Database Syst Rev. 2006;4:CD004080. doi:10.1002/
14651858.CD004080.pub2. Andersen HK, ed.
Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical
site infections in acute care hospitals: 2014 update. Infect Control Hosp
Epidemiol. 2014;35(6):605–27. doi:10.1086/676022.
Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for
predicting postoperative respiratory failure in men after major noncardiac
surgery. The National Veterans Administration Surgical Quality Improvement
Program. Ann Surg. 2000;232(2):242–53.
Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic
and perioperative considerations. Anesthesiology. 2009;110(5):1139–57.
doi:10.1097/ALN.0b013e31819f7aea.
Bellows CF, Mills KT, Kelly TN, Gagliardi G. Combination of oral non-absorbable
and intravenous antibiotics versus intravenous antibiotics alone in the
prevention of surgical site infections after colorectal surgery: a meta-analysis
of randomized controlled trials. Tech Coloproctol. 2011;15(4):385–95. doi:10.
1007/s10151-011-0714-4.
Cannon JA, Altom LK, Deierhoi RJ, et al. Preoperative oral antibiotics
reduce surgical site infection following elective colorectal resections.
Dis Colon Rectum. 2012;55(11):1160–6. doi:10.1097/DCR.
0b013e3182684fac.
Causey MW, Maykel JA, Hatch Q, Miller S, Steele SR. Identifying risk factors for
renal failure and myocardial infarction following colorectal surgery. J Surg
Res. 2011;170(1):32–7.
Cima R, Dankbar E, Lovely J, et al. Colorectal surgery surgical site infection
reduction program: a national surgical quality improvement
program—driven multidisciplinary single-institution experience. J Am Coll
Surg. 2013;216(1):23–33. doi:10.1016/j.jamcollsurg.2012.09.009.
Cressoni M, Cadringher P, Chiurazzi C, et al. Lung inhomogeneity in patients with
acute respiratory distress syndrome. Am J Respir Crit Care Med. 2014;189(2):
149–58. doi:10.1164/rccm.201308-1567OC.
Dahabreh IJ, Steele DW, Shah N, Trikalinos TA. Oral mechanical bowel
preparation for colorectal surgery: systematic review and meta-analysis. Dis
Colon Rectum. 2015;58(7):698–707. doi:10.1097/DCR.0000000000000375.
de Jesus EC, KAMDCAAA. Prophylactic anastomotic drainage for colorectal
surgery (review). 2009. p. 1–33.
DiFronzo LA, Yamin N, Patel K, O’Connell TX. Benefits of early feeding and early
hospital discharge in elderly patients undergoing open colon resection. J Am
Coll Surg. 2003;197(5):747–52. doi:10.1016/S1072-7515(03)00794-4.
Dindo DD, Demartines NN, Clavien P-AP. Classification of surgical complications:
a new proposal with evaluation in a cohort of 6336 patients and results of a
survey. Ann Surg. 2004;240(2):205–13.
Drolet S, Maclean AR, Myers RP, Shaheen AAM, Dixon E, Buie WD. Morbidity and
mortality following colorectal surgery in patients with end-stage renal failure:
a population-based study. Dis Colon Rectum. 2010;53(11):1508–16. doi:10.
1007/DCR.0b013e3181e8fc8e.
Eskesen TG, Wetterslev M, Perner A. Systematic review including re-analyses of 1148
individual data sets of central venous pressure as a predictor of fluid responsiveness.
Intensive Care Med. 2016;42(3):324–32. doi:10.1007/s00134-015-4168-4.
Gallart L, Canet J. Post-operative pulmonary complications: understanding
definitions and risk assessment. Best Pract Res Clin Anaesthesiol. 2015;29(3):
315–30. doi:10.1016/j.bpa.2015.10.004.
Giercksky KE, Danielsen S, Garberg O, et al. A single dose tinidazole and doxycycline
prophylaxis in elective surgery of colon and rectum. A prospective controlled
clinical multicenter study. Ann Surg. 1982;195(2):227–31.
Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a
risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr
Metab Care. 2003;6(3):327–33. doi:10.1097/01.mco.0000068970.34812.8b.
Gottlieb M, Hunter B. Utility of central venous pressure as a predictor of fluid
responsiveness. Ann Emerg Med. 2016;68(1):114–6. doi:10.1016/j.
annemergmed.2016.02.009.
Grasso S, Stripoli T, De Michele M, et al. ARDSnet ventilatory protocol and
alveolar hyperinflation: role of positive end-expiratory pressure. Am J Respir
Crit Care Med. 2007;176(8):761–7. doi:10.1164/rccm.200702-193OC.
Guenaga KF, Matos D, Wille-Jørgensen P. Mechanical bowel preparation for
elective colorectal surgery. Cochrane Database Syst Rev. 2011;(9):1–58.
Halabi WJ, Kang CY, Nguyen VQ, et al. Epidural analgesia in laparoscopic colorectal
surgery. JAMA Surg. 2014;149(2):130–7. doi:10.1001/jamasurg.2013.3186.
Han-Geurts IJM, Hop WCJ, Kok NFM, Lim A, Brouwer KJ, Jeekel J. Randomized
clinical trial of the impact of early enteral feeding on postoperative ileus and
recovery. Br J Surg. 2007;94(5):555–61. doi:10.1002/bjs.5753.
Hendry PO, Balfour A, Potter MA, et al. Preoperative conditioning with oral
carbohydrate loading and oral nutritional supplements can be combined
with mechanical bowel preparation prior to elective colorectal resection.
Colorectal Dis. 2008;10(9):907–10. doi:10.1111/j.1463-1318.2008.01499.x.
Hill MV, Holubar SD, Garfield Legare CI, Luurtsema CM, Barth RJ. Perioperative
bundle decreases postoperative hepatic surgery infections. Ann Surg Oncol.
2015;22(S3):1140–6. doi:10.1245/s10434-015-4584-2.
Holte K, Nielsen KG, Madsen JL, Kehlet H. Physiologic effects of bowel preparation.
Dis Colon Rectum. 2004;47(9):1397–402. doi:10.1007/s10350-004-0592-1.
Huang DB, DuPont HL. Rifaximin—a novel antimicrobial for enteric infections. J
Infect. 2005;50(2):97–106. doi:10.1016/j.jinf.2004.05.019.
Jafari MD, Wexner SD, Martz JE, et al. Perfusion assessment in laparoscopic left-
sided/anterior resection (PILLAR II): a multi-institutional study. ACS. 2015;
220(1):82–92.e1. doi:10.1016/j.jamcollsurg.2014.09.015.
Kacmarek RM, Villar J, Sulemanji D, et al. Open lung approach for the acute
respiratory distress syndrome: a pilot, randomized controlled trial. Crit Care
Med. 2016;44(1):32–42. doi:10.1097/CCM.0000000000001383.
Keenan JE, Speicher PJ, Nussbaum DP, et al. Improving outcomes in colorectal
surgery by sequential implementation of multiple standardized care
programs. J Am Coll Surg. 2015;221(2):404–14.e1. doi:10.1016/j.jamcollsurg.
2015.04.008.
Kin C, Rhoads KF, Jalali M, Shelton AA, Welton ML. Predictors of postoperative
urinary retention after colorectal surgery. Dis Colon Rectum. 2013a;56(6):738–
46. doi:10.1097/DCR.0b013e318280aad5.
Kiran RP, Murray ACA, Chiuzan C, Estrada D, Forde K. Combined
preoperative mechanical bowel preparation with oral antibiotics
Holubar et al. Perioperative Medicine  (2017) 6:4 Page 16 of 18
significantly reduces surgical site infection, anastomotic leak, and ileus
after colorectal surgery. Ann Surg. 2015;262(3):416–25. doi:10.1097/SLA.
0000000000001416.
Kirby DF, Delegge MH, Fleming CR. American Gastroenterological Association technical
review on tube feeding for enteral nutrition. YGAST. 1995;108(4):1282–301.
Langmore SE, Terpenning MS, Schork A, et al. Predictors of aspiration
pneumonia: how important is dysphagia? Dysphagia. 1998;13(2):69–81. doi:
10.1007/PL00009559.
Lavu H, Klinge MJ, Nowcid LJ, et al. Perioperative surgical care bundle reduces
pancreaticoduodenectomy wound infections. J Surg Res. 2012;174(2):215–21.
doi:10.1016/j.jss.2011.09.028.
Leuck A-M, Johnson JR, Hunt MA, et al. Safety and efficacy of a novel silver-
impregnated urinary catheter system for preventing catheter-associated
bacteriuria: a pilot randomized clinical trial. Am J Infect Control. 2015;43(3):
260–5. doi:10.1016/j.ajic.2014.11.021.
Lewis SJ, Andersen HK, Thomas S. Early enteral nutrition within 24 h of intestinal
surgery versus later commencement of feeding: a systematic review and meta-
analysis. J Gastrointest Surg. 2008;13(3):569–75. doi:10.1007/s11605-008-0592-x.
Meade MO, Cook DJ, Guyatt GH, et al. Ventilation strategy using low tidal
volumes, recruitment maneuvers, and high positive end-expiratory pressure
for acute lung injury and acute respiratory distress syndrome: a randomized
controlled trial. JAMA. 2008;299(6):637–45. doi:10.1001/jama.299.6.637.
Mercat A, Richard J-CM, Vielle B, et al. Positive end-expiratory pressure setting in adults
with acute lung injury and acute respiratory distress syndrome—a randomized
controlled trial. JAMA. 2008;299(6):646–55. doi:10.1001/jama.299.6.646.
Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern
Med. 2000;132(5):391–402. doi:10.7326/0003-4819-132-5-200003070-00009.
Midura EF, Hanseman D, Davis BR, et al. Risk factors and consequences of
anastomotic leak after colectomy: a national analysis. Dis Colon Rectum.
2015;58(3):333–8. doi:10.1097/DCR.0000000000000249.
Miller TE, Thacker JK, White WD, et al. Reduced length of hospital stay in
colorectal surgery after implementation of an enhanced recovery protocol.
Anesth Analg. 2014;118(5):1052–61. doi:10.1213/ANE.0000000000000206.
Moghadamyeghaneh Z, Hanna MH, Carmichael JC, et al. Nationwide analysis of
outcomes of bowel preparation in colon surgery. J Am Coll Surg. 2015;
220(5):912–20. doi:10.1016/j.jamcollsurg.2015.02.008.
Morris MS, Graham LA, Chu DI, Cannon JA, Hawn MT. Oral antibiotic bowel
preparation significantly reduces surgical site infection rates and readmission
rates in elective colorectal surgery. Ann Surg. 2015;261(6):1034–40. doi:10.
1097/SLA.0000000000001125.
Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical
practice guidelines for ventilator-associated pneumonia: prevention. J Crit
Care. 2008;23(1):126–37. doi:10.1016/j.jcrc.2007.11.014.
Nelson R, Edwards S, Tse B. Prophylactic nasogastric decompression after
abdominal surgery. Cochrane Database Syst Rev. 2007;3:CD004929. doi:10.
1002/14651858.CD004929.pub3. Nelson RL, ed.
Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery.
Cochrane Database Syst Rev. 2009;(1):CD001181. doi:10.1002/14651858.
CD001181.pub3.
Neto AS, Hemmes SNT, Barbas CSV, et al. Association between driving pressure
and development of postoperative pulmonary complications in patients
undergoing mechanical ventilation for general anaesthesia: a meta-analysis
of individual patient data. Lancet Respir Med. 2016;4(4):272–80. doi:10.1016/
S2213-2600(16)00057-6.
Nichols RL, Broido P, Condon RE, Gorbach SL, Nyhus LM. Effect of preoperative
neomycin-erythromycin intestinal preparation on the incidence of infectious
complications following colon surgery. Ann Surg. 1973;178(4):453–62.
Nicholson GA, Finlay IG, Diament RH, Molloy RG, Horgan PG, Morrison DS.
Mechanical bowel preparation does not influence outcomes following
colonic cancer resection. Br J Surg. 2011;98(6):866–71. doi:10.1002/bjs.7454.
Ofstad E, Brabrand G, Helsingen N. Tinidazole and doxycycline as antimicrobials
in elective colorectal surgery. A randomized multicentre trial. Scand J
Gastroenterol Suppl. 1980;59:29-35.
Ojetti VV, Lauritano ECE, Barbaro FF, et al. Rifaximin pharmacology and clinical
implications. Audio, Transactions of the IRE Professional Group on. 2009;5(6):
675–82. doi:10.1517/17425250902973695.
Olivas AD, Shogan BD, Valuckaite V, et al. Intestinal tissues induce an SNP mutation in
Pseudomonas aeruginosa that enhances its virulence: possible role in anastomotic
leak. PLoS ONE. 2012;7(8), e44326. doi:10.1371/journal.pone.0044326.
Patel JM, Baker R, Yeung J, Small C, West Midlands-Trainee Research and Audit
Network (WM-TRAIN). Intra-operative adherence to lung-protective
ventilation: a prospective observational study. Perioper Med (Lond). 2016;5(1):
8. doi:10.1186/s13741-016-0033-4.
Pfefferkorn U, Sanlav L, Moldenhauer J, Peterli R, von Flüe M, Ackermann C.
Antibiotic prophylaxis at urinary catheter removal prevents urinary tract
infections. Ann Surg. 2009;249(4):573–5. doi:10.1097/SLA.0b013e31819a0315.
Pineda CE, Shelton AA, Hernandez-Boussard T, Morton JM, Welton ML.
Mechanical bowel preparation in intestinal surgery: a meta-analysis and
review of the literature. J Gastrointest Surg. 2008;12(11):2037–44. doi:10.1007/
s11605-008-0594-8.
Poylin V, Curran T, Cataldo T, Nagle D. Perioperative use of tamsulosin significantly
decreases rates of urinary retention in men undergoing pelvic surgery. Int J
Colorectal Dis. 2015;30(9):1223–8. doi:10.1007/s00384-015-2294-7.
Reinbold C, Rausky J, Binder J-P, Revol M. Urinary cotinine testing as pre-
operative assessment of patients undergoing free flap surgery. Ann Chir Plast
Esthet. 2015;60(1):e51–7. doi:10.1016/j.anplas.2014.10.002.
Rosendal C, Markin S, Hien MD, Motsch J, Roggenbach J. Cardiac and
hemodynamic consequences during capnoperitoneum and steep
Trendelenburg positioning: lessons learned from robot-assisted laparoscopic
prostatectomy. J Clin Anesth. 2014;26(5):383–9.
Holubar SD. Preoperative medical prophylaxis of postoperative complications. In:
Enhanced recovery for major abdominopelvic surgery. NY: PCI Books; 2016. p. 1–7.
Serpa Neto A, Hemmes SNT, Barbas CSV, et al. Protective versus conventional
ventilation for surgery: a systematic review and individual patient data meta-
analysis. Anesthesiology. 2015;123(1):66–78. doi:10.1097/ALN.
0000000000000706.
Shah H, Bosch W, Thompson KM, Hellinger WC. Intravascular catheter-related
bloodstream infection. Neurohospitalist. 2013;3(3):144–51. doi:10.1177/
1941874413476043.
Shakhsheer BA, Versten LA, Luo JN, et al. Morphine promotes colonization of
anastomotic tissues with collagenase—producing Enterococcus faecalis and
causes leak. J Gastrointest Surg. 2016;20(10):1744–51. doi:10.1007/s11605-016-
3237-5. PubMed—NCBI.
Shogan BD, Carlisle EM, Alverdy JC, Umanskiy K. Do we really know why
colorectal anastomoses leak? J Gastrointest Surg. 2013;17(9):1698–707. doi:10.
1007/s11605-013-2227-0.
Slim K, Vicaut E, Launay-Savary M-V, Contant C, Chipponi J. Updated systematic
review and meta-analysis of randomized clinical trials on the role of
mechanical bowel preparation before colorectal surgery. Ann Surg. 2009;
249(2):203–9. doi:10.1097/SLA.0b013e318193425a.
Spieth PM, Carvalho AR, Pelosi P, et al. Variable tidal volumes improve lung
protective ventilation strategies in experimental lung injury. Am J Respir Crit
Care Med. 2009;179(8):684–93. doi:10.1164/rccm.200806-975OC.
Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G. Inpatient
costs, mortality and 30-day re-admission in patients with central-line-
associated bloodstream infections. Clin Microbiol Infect. 2014;20(5):O318–24.
doi:10.1111/1469-0691.12407.
Sutherland T, Beloff J, McGrath C, et al. A single-center multidisciplinary initiative
to reduce catheter-associated urinary tract infection rates. The Health Care
Manager. 2015;34(3):218–24. doi:10.1097/HCM.0000000000000073.
Talmor D, Sarge T, Malhotra A, et al. Mechanical ventilation guided by
esophageal pressure in acute lung injury. N Engl J Med. 2008;359(20):2095–
104. doi:10.1056/NEJMoa0708638.
Tambyah PA. Catheter-associated urinary tract infections: diagnosis and prophylaxis.
Int J Antimicrob Agents. 2004;24:S44–8. doi:10.1016/j.ijantimicag.2004.02.008.
Thiele RH, Rea KM, Turrentine FE, et al. Standardization of care: impact of an
enhanced recovery protocol on length of stay, complications, and direct
costs after colorectal surgery. J Am Coll Surg. 2015;220(4):430–43. doi:10.
1016/j.jamcollsurg.2014.12.042.
Toneva GD, Deierhoi RJ, Morris M, et al. Oral antibiotic bowel preparation
reduces length of stay and readmissions after colorectal surgery. J Am Coll
Surg. 2013;216(4):756–62. doi:10.1016/j.jamcollsurg.2012.12.039.
Vlug MS, Wind J, Hollmann MW, et al. Laparoscopy in combination with fast track
multimodal management is the best perioperative strategy in patients
undergoing colonic surgery. Ann Surg. 2011;254(6):868–75. doi:10.1097/SLA.
0b013e31821fd1ce.
Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the
postoperative period: analysis of the national surgical infection prevention
project data. Arch Surg. 2008;143(6):551–7. doi:10.1001/archsurg.143.6.551.
Walter CJ, Collin J, Dumville JC, Drew PJ, Monson JR. Enhanced recovery in
colorectal resections: a systematic review and meta-analysis. Color Dis. 2009;
11(4):344–53. doi:10.1111/j.1463-1318.2009.01789.x.
Holubar et al. Perioperative Medicine  (2017) 6:4 Page 17 of 18
Yang CK, Teng A, Lee DY, Rose K. Pulmonary complications after major
abdominal surgery: National Surgical Quality Improvement Program analysis.
J Surg Res. 2015;198(2):441–9. doi:10.1016/j.jss.2015.03.028.
Yokoe DS, Anderson DJ, Berenholtz SM, et al. A compendium of strategies to
prevent healthcare-associated infections in acute care hospitals: 2014
updates. Am J Infect Control. 2014;42(8):820–8. doi:10.1016/j.ajic.2014.07.002.
Yoshida T, Torsani V, Gomes S, et al. Spontaneous effort causes occult pendelluft
during mechanical ventilation. Am J Respir Crit Care Med. 2013;188(12):1420–7.
doi:10.1164/rccm.201303-0539OC.
Zargar-Shoshtari K, Paddison JS, Booth RJ, Hill AG. A prospective study on the
influence of a fast-track program on postoperative fatigue and functional
recovery after major colonic surgery. J Surg Res. 2009;154(2):330–5. doi:10.
1016/j.jss.2008.06.023.
Zhang H-Y, Zhao C-L, Xie J, et al. To drain or not to drain in colorectal
anastomosis: a meta-analysis. Int J Colorectal Dis. 2016;31(5):951–60.
doi:10.1007/s00384-016-2509-6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Holubar et al. Perioperative Medicine  (2017) 6:4 Page 18 of 18
